Custom Antibody Services Market Research, 2033
The global custom antibody services market size was valued at $0.6 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 8.7% from 2024 to 2033. The increasing demand for personalized medicine, advancements in biotechnology that enable precise antibody development, and the growing need for targeted therapies and diagnostics in research and clinical applications are the major factors which drives the market growth.
Market Introduction and Definition
Custom antibody services involve the development and production of specific antibodies tailored to a client's unique requirements. These services include the creation of monoclonal or polyclonal antibodies against particular antigens, which are proteins or other molecules that elicit an immune response. The process typically encompasses antigen design, immunization of host animals (such as mice, rabbits, or goats) , antibody screening, and purification. Custom antibody services are crucial for various applications in research, diagnostics, and therapeutic development, providing highly specific tools for detecting, quantifying, and studying proteins and other biomolecules within complex biological samples.
Key Takeaways
The custom antibody services market share study covers 20 countries. The research includes a segment analysis of each country in terms of value for the projected period.
More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major custom antibody services industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
The study integrated high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach is intended to provide a balanced view of global markets and to assist stakeholders in making educated decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The custom antibody services market growth is driven by the rise in prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders which has amplified the need for precise diagnostics and therapeutics, where custom antibodies play a critical role. Researchers and pharmaceutical companies require specific antibodies to identify and target unique biomarkers associated with these diseases, leading to a surge in demand for custom antibody services.
In addition, the expansion of the biotechnology and pharmaceutical industries significantly propels the custom antibody services market size. With ongoing advancements in these sectors, there is a growing need for high-quality, specific antibodies for drug discovery and development. Custom antibodies are instrumental in screening potential drug candidates, understanding disease mechanisms, and developing targeted therapies. This led to increased investments in custom antibody production, fostering antibody services market size.
Furthermore, advancements in antibody production technologies have made custom antibody services more efficient and cost-effective which further supports market growth. Techniques such as phage display, hybridoma technology, and recombinant DNA technology have revolutionized antibody production, enabling the generation of highly specific and high-affinity antibodies. These technological advancements have reduced production time and costs, making custom antibody services more accessible to a broader range of researchers and companies.
Additionally, the increasing focus on research and development in life sciences is a major driving factor for the market growth. Academic institutions, research organizations, and pharmaceutical companies are investing heavily in R&D to discover new treatments and diagnostics. Custom antibodies are essential tools in basic and applied research, facilitating the study of complex biological systems and disease pathways. The continuous need for novel antibodies in various research applications drives growth during the custom antibody services market forecast period.
However, the high cost associated with custom antibody production is a significant barrier for the market growth. Developing specific antibodies involves intricate processes, including antigen design, immunization, screening, and purification, all of which require substantial financial investment. Smaller research institutions and companies may find these costs prohibitive, limiting their ability to utilize custom antibody services extensively thereby restraining the market growth. On the other hand, the increasing adoption of personalized medicine offers significant custom antibody services market opportunity. Personalized medicine aims to tailor medical treatments to individual patient characteristics, including genetic makeup and biomarker profiles. In addition, the increasing focus on R&D in life sciences and biotechnology presents opportunities for custom antibody services providers.
Prevalence of Chronic Conditions
According to the Centers for Disease Control and Prevention (CDC) , the prevalence of chronic conditions such as cancer affected 1.7 million individuals, diabetes was prevalent among 38 million people, and arthritis impacted 53.2 million people. These chronic conditions highlight the extensive prevalence of disease on the healthcare system and drives the necessity for advanced therapeutic and diagnostic solutions. The custom antibody services market plays a crucial role in addressing these health challenges. Custom antibodies are essential tools in the development of targeted therapies, diagnostics, and personalized medicine. For instance, in cancer treatment, custom antibodies can be designed to target specific tumor markers, improving the efficacy of treatments and reducing side effects. In diabetes management, antibodies can aid in the development of diagnostic tests that detect biomarkers for early diagnosis and monitoring. Similarly, for arthritis, custom antibodies can be utilized in research to understand the underlying mechanisms of the disease and to develop novel therapeutic approaches. The growing prevalence of chronic conditions drives the demand for innovative healthcare solutions, positioning the custom antibody services market.
Market Segmentation
The custom antibody services market is segmented into service, type, source, application, end user, and region. On the basis of the service, the market is segmented into antibody development, antibody production & purification, and antibody fragmentation & labeling. By type, the market is classified into monoclonal antibodies, polyclonal antibodies, recombinant antibodies, and others. By source, the market is divided into mice, rabbit, and others. On the basis of application, the market is segregated into oncology, infectious diseases, neurology, immunology, cardiovascular diseases, and others. By end user, the market is classified into pharmaceutical & biotechnology companies, academic & research institutes, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional/Country Market Outlook
North America plays a pivotal role in custom antibody services market share owing to advanced healthcare infrastructure, high adoption rates of wearable technology, and strong focus on innovative healthcare solutions. In addition, the rise in prevalence of chronic diseases and increase in emphasis on remote patient monitoring further drive market growth. Asia-Pacific is witnessing rapid growth driven by expanding healthcare infrastructure, the rise in prevalence of chronic diseases, and the aging population which is driving the demand for continuous health monitoring solutions. In addition, rise in technological advancements and the adoption of telemedicine and remote patient monitoring are further propelling market growth in this region.
Industry Trends
The National Institutes of Health (NIH) is the largest public funder of biomedical research in the world. In fiscal year 2022, NIH invested most of its $45 billion appropriations in research seeking to enhance life, and to reduce illness and disability which directly supports custom antibody development services market growth.
European Union's Horizon Europe program has committed approximately €95.5 billion ($103 billion) for research and innovation projects from 2021 to 2027, significantly benefiting antibody research initiatives.
Competitive Landscape
The major players operating in the custom antibody services market include Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., Sino Biological, Inc., Bio-Rad Laboratories, Inc, Kaneka Eurogentec S.A., YenZym Antibodies, LLC., OriGene Technologies, Inc.?, Laboratory Corporation of America Holdings, and GenScript.
Recent Key Strategies and Developments in Custom Antibody Services Industry
In December 2021, ??Thermo Fisher Scientific Inc., the world leader in serving science, announced that it has completed its acquisition of PPD, Inc., a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion.
Key Sources Referred
- National Center for Biotechnology and Information (NCBI)
- Centers for Medicare & Medicaid Services (CMS)
- National Health Service (NHS)
- Australian Government Department of Health and Aged Care
- Government of Canada's Health and Wellness
- Ministry of Health and Family Welfare (MoHFW)
- National Health Mission (NHM)
- Ayushman Bharat - Health and Wellness Centres (AB-HWCs)
- Centers for Disease Control and Prevention (CDC)
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the custom antibody services market analysis from 2024 to 2033 to identify the prevailing custom antibody services market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the custom antibody services market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global custom antibody services market trends, key players, market segments, application areas, and market growth strategies.
Custom Antibody Services Market , by Service Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 1.4 Billion |
 Growth Rate | CAGR of 8.7% |
 Forecast period | 2024 - 2033 |
 Report Pages | 233 |
 By Service |
|
 By Type |
|
 By Source |
|
 By Application |
|
 By End User |
|
 By Region |
|
 Key Market Players | Sino Biological, Inc., Laboratory Corporation of America Holdings., Agilent Technologies, Inc., Kaneka Eurogentec S.A., GenScript, Thermo Fisher Scientific Inc., YenZym Antibodies, LLC., Bio-Rad Laboratories, Inc, OriGene Technologies, Inc. , Merck KGaA |
The total market value of custom antibody services market is $0.6 billion in 2023.
The forecast period for custom antibody services market is 2024 to 2033.
The market value of custom antibody services market in 2033 is $1.4 billion.
The growth of the custom antibody services market is driven by the increasing demand for personalized medicine and targeted therapies, advancements in biotechnology and antibody engineering, and the rising need for precise diagnostic tools and research applications.
Custom antibody services involve the development and production of tailored antibodies specific to a client’s research, diagnostic, or therapeutic needs. This includes monoclonal and polyclonal antibodies designed for unique targets.
Loading Table Of Content...
